---
figid: PMC11747375__fphar-15-1515172-g003
figtitle: GA inhibited the proliferation and migration of VSMCs
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11747375
filename: fphar-15-1515172-g003.jpg
figlink: /pmc/articles/PMC11747375/figure/F3/
number: F3
caption: 'GA inhibited the proliferation and migration of VSMCs. Green arrows and
  red arrows indicate promotion and inhibition, respectively. Description: This figure
  illustrates how GA inhibits VSMC proliferation and migration while inducing apoptosis.
  GA suppresses the RhoA/CDC42 and PI3K-Akt-ERK1/2 pathways, reduces the activation
  of NF-κB and Ras, and increases the expression of iNOS and KSR2. Additionally, GA
  promotes the AMPK-eNOS-FAS pathway, enhances Kip1/p27 and Cip1/p21 levels, and inhibits
  the expression of cyclin B1 and CDK1. Moreover, GA reduces hydroxyl radicals and
  alleviates oxidative stress to induce apoptosis. Green arrows indicate promoting
  effects, while red arrows represent inhibitory effects'
papertitle: 'Gallic acid: a dietary metabolite’s therapeutic potential in the management
  of atherosclerotic cardiovascular disease'
reftext: Xiao-Lan Zhao, et al. Front Pharmacol. 2024;15(NA).
year: '2024'
doi: 10.3389/fphar.2024.1515172
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: gallic acid | diabetes | hypertension | hyperlipidemia | atherosclerosis
  | ASCVD | cardio-vascular diseases
automl_pathway: 0.9297905
figid_alias: PMC11747375__F3
figtype: Figure
redirect_from: /figures/PMC11747375__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11747375__fphar-15-1515172-g003.html
  '@type': Dataset
  description: 'GA inhibited the proliferation and migration of VSMCs. Green arrows
    and red arrows indicate promotion and inhibition, respectively. Description: This
    figure illustrates how GA inhibits VSMC proliferation and migration while inducing
    apoptosis. GA suppresses the RhoA/CDC42 and PI3K-Akt-ERK1/2 pathways, reduces
    the activation of NF-κB and Ras, and increases the expression of iNOS and KSR2.
    Additionally, GA promotes the AMPK-eNOS-FAS pathway, enhances Kip1/p27 and Cip1/p21
    levels, and inhibits the expression of cyclin B1 and CDK1. Moreover, GA reduces
    hydroxyl radicals and alleviates oxidative stress to induce apoptosis. Green arrows
    indicate promoting effects, while red arrows represent inhibitory effects'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RHOA
  - CDC42
  - RAC1
  - RNASE1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - ENO4
  - MAPK3
  - MAPK1
  - FAS
  - FASN
  - NFKB1
  - KRAS
  - HRAS
  - NRAS
  - NOS2
  - ISYNA1
  - PTEN
  - KSR2
  - CNKSR2
  - B3GNT2
  - B3GNTL1
  - CDK1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDKN1B
  - CIB1
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - SLC12A9
  - Gallic acid
  - FAS
  - -OH
---
